What is the main purpose of the amendment to the Executive Retirement Plan?

The amendment primarily modifies the eligibility requirements for certain high-level executive roles, specifically those holding the highest president position within a global division, region, or country. To remain eligible under the new terms, such individuals must have been serving in that specific role since before August 1, 2015. This is intended to potentially refine eligibility for future senior appointments while protecting current participants.

Will current participants in the Executive Retirement Plan be affected by the changes?

No, the company explicitly states that the amendments are designed to ensure continued eligibility for all employees who are currently eligible to participate in the Executive Retirement Plan. This means existing beneficiaries should not see any disruption to their current participation status.

Why was Edward J. Mackey's compensation increased?

The 8-K filing does not provide the specific reasoning behind the compensation adjustment for Edward J. Mackey, Executive Vice President of Operations. Such decisions are typically made by the Compensation Committee and can be influenced by various factors including performance, market competitiveness, and role responsibilities. Investors should note that this appears to be an individual adjustment.

Are there any significant financial implications from these changes for Boston Scientific?

The filing does not detail immediate significant financial implications. The retirement plan amendment focuses on eligibility criteria rather than immediate payout changes, and the executive compensation adjustment is for one individual. The primary financial impact would be the ongoing cost of executive compensation and retirement benefits, which are standard operational expenses.

BSX 8-K: Leadership Changes

Summary

Boston Scientific Corporation (BSX) filed an 8-K on July 28, 2016, reporting on changes to its Executive Retirement Plan and a compensation adjustment for a named executive officer. The primary focus is the amendment and restatement of the Executive Retirement Plan, effective August 1, 2016. This amendment introduces a new eligibility requirement for certain high-level divisional/regional president roles, mandating at least one year of service in that specific position prior to August 1, 2015, to remain eligible. However, the company emphasizes that all current participants will retain their eligibility under the revised terms, mitigating immediate concern for existing beneficiaries. Additionally, the filing discloses a compensation increase for Edward J. Mackey, Executive Vice President of Operations, effective July 25, 2016. His annual base salary was raised to $495,000, representing a 5.3% increase. This adjustment appears to be an isolated event for a specific executive and should be viewed within the broader context of executive compensation strategies rather than a company-wide salary action.

Key Highlights

1Amendment and restatement of the Boston Scientific Corporation Executive Retirement Plan, effective August 1, 2016.
2New eligibility criteria for certain 'highest president' positions within global divisions/regions: requires service in that role since prior to August 1, 2015.
3Assurance provided that all current employees eligible for the Executive Retirement Plan will maintain their eligibility.
4Compensation increase for Edward J. Mackey, EVP of Operations, to $495,000 annual base salary.
5Mr. Mackey's salary increase represents a 5.3% adjustment.
6The compensation adjustment for Mr. Mackey was effective July 25, 2016.
7The filing includes the amended and restated Executive Retirement Plan as an exhibit.

BOSTON SCIENTIFIC CORP 8-K Report, Executive Changes (Jul 28, 2016)

Summary

Key Highlights

Frequently Asked Questions